Eagle Health Investments LP - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 248 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.

Quarter-by-quarter ownership
Eagle Health Investments LP ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q2 2022$8,615,000
-20.9%
170,5510.0%2.01%
-25.1%
Q1 2022$10,895,000
-47.2%
170,551
-11.5%
2.68%
-46.6%
Q4 2021$20,634,000
+13.9%
192,639
+9.3%
5.03%
-12.5%
Q3 2021$18,113,000
+46.3%
176,175
+25.2%
5.74%
+35.2%
Q2 2021$12,382,000
-4.4%
140,763
+5.7%
4.25%
-16.4%
Q1 2021$12,947,000
+86.0%
133,163
+114.6%
5.08%
+14.2%
Q4 2020$6,960,00062,0604.45%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 645,539$69,144,0007.84%
DAFNA Capital Management LLC 206,911$22,162,0005.57%
Eagle Health Investments LP 192,639$20,634,0005.03%
Casdin Capital, LLC 1,550,000$166,021,0004.68%
CADIAN CAPITAL MANAGEMENT, LP 450,657$48,270,0002.65%
Avidity Partners Management LP 995,000$106,574,0002.26%
Integral Health Asset Management, LLC 75,000$8,033,0002.22%
Rock Springs Capital Management LP 859,755$92,088,0002.13%
Boxer Capital, LLC 507,374$54,345,0002.11%
EFG Asset Management (North America) Corp. 112,715$12,082,0001.58%
View complete list of BLUEPRINT MEDICINES CORP shareholders